Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Introduction Commercial off-the-shelf (COTS) intravenous fluid (IVF) containers contain residual air, introducing the risk of venous air embolism (VAE). Venous air embolism occurs when air displaces blood flow in vasculature. The danger from residual air is often negligible in terrestrial settings, where gravitational forces generate buoyancy, pushing residual air to the top of the IVF container. However, in microgravity there is no buoyancy to separate liquid and gas layers. We performed experiments to quantify the amount of air in COTS IVF containers (Experiment 1) and identify the variables that affect the stability of sterilely produced airless containers (Experiment 2). Materials and Methods Experiment 1: Residual air was quantified across varying volumes (100, 250, 500, and 1,000 mL), container design, and manufacturer (B. Braun, Baxter, ICU Medical, and Grifols) of 0.9% NaCl COTS IVFs. Each container was assessed for absolute volumes of air, as well as air:fluid ratios normalized to 1,000 mL. Experiment 2: 1,000 mL IVF containers from 3 manufacturers were filled with either (1) 100% saline or (2) 95% saline and 5% air by volume. Containers were stored for 168 days at 25°C or 40 °C. The containers were optically imaged to quantify the accumulation of air within each IVF container. Results Experiment 1: There was a trend toward larger container sizes and greater absolute volumes of residual air (R2 = 0.964). However, the smallest air:volume ratio occurred in the Baxter 500 mL VIAFLO Container (18.9 ± 3.8 mL air; 2.3% air by volume), whereas the largest ratio occurred in the B. Braun 250 mL EXCEL Container (55.0 ± 9.3 mL; 22.0% air by volume). Experiment 2: By day 168, 6 experimental containers had ruptured and 100% of the surviving containers (30/36) had an increase in air as compared to baseline. Containers placed at 40 °C had a larger increase in air (27.7 ± 6.6 mL) compared to containers stored at 25 °C (7.5 ± 4.1 mL; P < .0001). Conclusions Residual air has a wide variety of volumes in COTS IVFs. The average amount of residual air is high enough to contribute to clinically significant VAEs, although unlikely to be fatal. If airless IVF containers are produced for exploration missions, a progressive increase in the amount of residual air should be expected. Extremes of temperatures and humidity will increase the reaccumulation of residual air and decrease the shelf-life of airless IVFs.
Introduction Commercial off-the-shelf (COTS) intravenous fluid (IVF) containers contain residual air, introducing the risk of venous air embolism (VAE). Venous air embolism occurs when air displaces blood flow in vasculature. The danger from residual air is often negligible in terrestrial settings, where gravitational forces generate buoyancy, pushing residual air to the top of the IVF container. However, in microgravity there is no buoyancy to separate liquid and gas layers. We performed experiments to quantify the amount of air in COTS IVF containers (Experiment 1) and identify the variables that affect the stability of sterilely produced airless containers (Experiment 2). Materials and Methods Experiment 1: Residual air was quantified across varying volumes (100, 250, 500, and 1,000 mL), container design, and manufacturer (B. Braun, Baxter, ICU Medical, and Grifols) of 0.9% NaCl COTS IVFs. Each container was assessed for absolute volumes of air, as well as air:fluid ratios normalized to 1,000 mL. Experiment 2: 1,000 mL IVF containers from 3 manufacturers were filled with either (1) 100% saline or (2) 95% saline and 5% air by volume. Containers were stored for 168 days at 25°C or 40 °C. The containers were optically imaged to quantify the accumulation of air within each IVF container. Results Experiment 1: There was a trend toward larger container sizes and greater absolute volumes of residual air (R2 = 0.964). However, the smallest air:volume ratio occurred in the Baxter 500 mL VIAFLO Container (18.9 ± 3.8 mL air; 2.3% air by volume), whereas the largest ratio occurred in the B. Braun 250 mL EXCEL Container (55.0 ± 9.3 mL; 22.0% air by volume). Experiment 2: By day 168, 6 experimental containers had ruptured and 100% of the surviving containers (30/36) had an increase in air as compared to baseline. Containers placed at 40 °C had a larger increase in air (27.7 ± 6.6 mL) compared to containers stored at 25 °C (7.5 ± 4.1 mL; P < .0001). Conclusions Residual air has a wide variety of volumes in COTS IVFs. The average amount of residual air is high enough to contribute to clinically significant VAEs, although unlikely to be fatal. If airless IVF containers are produced for exploration missions, a progressive increase in the amount of residual air should be expected. Extremes of temperatures and humidity will increase the reaccumulation of residual air and decrease the shelf-life of airless IVFs.
Space medicine is a multidisciplinary field that requires the integration of medical imaging techniques and expertise in diagnosing and treating a wide range of acute and chronic conditions to maintain astronaut health. Medical imaging within this domain has been viewed historically through the lens of inflight point-of-care ultrasound and predominantly research uses of cross-sectional imaging before and after flight. However, space radiology, a subfield defined here as the applications of imaging before, during, and after spaceflight, will grow to necessitate the involvement of more advanced imaging techniques and subspecialist expertise as missions increase in length and complexity. While the performance of imaging in spaceflight is limited by equipment mass and volume, power supply, radiation exposure, communication delays, and personnel training, recent developments in nonsonographic modalities have opened the door to their potential for in-mission use. Additionally, improved exam protocols and scanner technology in combination with artificial intelligence algorithms have greatly advanced the utility of possible pre- and postflight studies. This article reviews the past and present of space radiology and discusses possible use cases, knowledge gaps, and future research directions for radiography, fluoroscopy, computed tomography, and magnetic resonance imaging within space medicine, including both the performance of new exam types for new indications and the increased extraction of information from exams already routinely obtained. Through thoughtfully augmenting the use of these tools, medical mission risk may be reduced substantially through preflight screening, inflight diagnosis and management, and inflight and postflight surveillance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Copyright © 2025 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.